D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 96 Citations 38,573 479 World Ranking 4563 National Ranking 2585

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Surgery
  • Cancer

Her primary scientific interests are in Pathology, Nephrectomy, Renal cell carcinoma, Surgery and Carcinoma. Her Nephrectomy research integrates issues from Renal function, Kidney disease and Urology. Her Renal cell carcinoma research is multidisciplinary, relying on both Survival rate, Cancer, Primary tumor and Stage.

Her research in Surgery intersects with topics in Radiology, Nephron sparing surgery, Cohort and Risk factor. Her studies deal with areas such as Clear cell renal cell carcinoma and Anatomical pathology as well as Carcinoma. Her study focuses on the intersection of Internal medicine and fields such as Oncology with connections in the field of Metastasis.

Her most cited work include:

  • An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. (869 citations)
  • Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. (858 citations)
  • Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. (848 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of investigation include Surgery, Renal cell carcinoma, Internal medicine, Nephrectomy and Pathology. Her studies in Surgery integrate themes in fields like Incidence and Cohort. As a part of the same scientific family, she mostly works in the field of Renal cell carcinoma, focusing on Carcinoma and, on occasion, Stage.

Her Internal medicine research incorporates elements of Gastroenterology, Oncology and Cardiology. Her Nephrectomy study combines topics from a wide range of disciplines, such as Survival rate, Clear cell renal cell carcinoma, Kidney disease and Urology. Her biological study spans a wide range of topics, including Cancer research and Clear cell carcinoma.

She most often published in these fields:

  • Surgery (30.49%)
  • Renal cell carcinoma (28.81%)
  • Internal medicine (26.63%)

What were the highlights of her more recent work (between 2018-2021)?

  • Schwannoma (5.03%)
  • Internal medicine (26.63%)
  • Nephrectomy (26.30%)

In recent papers she was focusing on the following fields of study:

Christine M. Lohse spends much of her time researching Schwannoma, Internal medicine, Nephrectomy, Renal cell carcinoma and Hazard ratio. The Schwannoma study combines topics in areas such as Microsurgery, Pediatrics, Vestibular system and Cohort. Her Internal medicine research includes elements of Oncology and Anxiety.

Her study explores the link between Nephrectomy and topics such as Urology that cross with problems in Pathological. Her primary area of study in Renal cell carcinoma is in the field of Clear cell renal cell carcinoma. Her Hazard ratio research integrates issues from Dental implant, Implant failure, Implant, Interquartile range and Proportional hazards model.

Between 2018 and 2021, her most popular works were:

  • Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma (29 citations)
  • Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. (28 citations)
  • JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management. (23 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

Christine M. Lohse mainly investigates Hazard ratio, Renal cell carcinoma, Internal medicine, Schwannoma and Cohort. Her research in Renal cell carcinoma intersects with topics in Cancer and Nephrectomy. Her research on Cancer also deals with topics like

  • Chromosome 7 and related Immunohistochemistry, Pathology and Fluorescence in situ hybridization,
  • Epigenetics together with Cancer research.

Her research integrates issues of Pathological, Radiofrequency ablation, Clear cell and Urology in her study of Nephrectomy. Her research on Internal medicine frequently links to adjacent areas such as Oncology. She combines subjects such as Surgery and Univariate analysis with her study of Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

John A. Heit;W. Michael O'Fallon;Tanya M. Petterson;Christine M. Lohse.
JAMA Internal Medicine (2002)

1396 Citations

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

John C. Cheville;Christine M. Lohse;Horst Zincke;Amy L. Weaver.
The American Journal of Surgical Pathology (2003)

1194 Citations

An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

Igor Frank;Michael L. Blute;John C. Cheville;Christine M. Lohse.
The Journal of Urology (2002)

1138 Citations

Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size

Igor Frank;Michael L. Blute;John C. Cheville;Christine M. Lohse.
The Journal of Urology (2003)

1120 Citations

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

R. Houston Thompson;Susan M. Kuntz;Bradley C. Leibovich;Haidong Dong.
Cancer Research (2006)

940 Citations

The epidemiology of venous thromboembolism in the community.

John A. Heit;Marc D. Silverstein;David N. Mohr;Tanya M. Petterson.
Thrombosis and Haemostasis (2001)

808 Citations

Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy

Bradley C. Leibovich;Michael L. Blute;John C. Cheville;Christine M. Lohse.
The Journal of Urology (2004)

776 Citations

Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy

R. Houston Thompson;Stephen A. Boorjian;Christine M. Lohse;Bradley C. Leibovich.
The Journal of Urology (2008)

771 Citations

Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy

R. Houston Thompson;Brian R. Lane;Christine M. Lohse;Bradley C. Leibovich.
European Urology (2010)

727 Citations

Meningioma grading: an analysis of histologic parameters.

Arie Perry;Scott L. Stafford;Bernd W. Scheithauer;Vera J. Suman.
The American Journal of Surgical Pathology (1997)

679 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christine M. Lohse

Paul Russo

Paul Russo

Memorial Sloan Kettering Cancer Center

Publications: 135

Robert G. Uzzo

Robert G. Uzzo

Fox Chase Cancer Center

Publications: 114

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 104

Christopher G. Wood

Christopher G. Wood

The University of Texas MD Anderson Cancer Center

Publications: 102

Allan J. Pantuck

Allan J. Pantuck

University of California, Los Angeles

Publications: 101

Inderbir S. Gill

Inderbir S. Gill

University of Southern California

Publications: 99

Arie S. Belldegrun

Arie S. Belldegrun

University of California, Los Angeles

Publications: 97

Bradley C. Leibovich

Bradley C. Leibovich

Mayo Clinic

Publications: 93

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 93

R. Houston Thompson

R. Houston Thompson

Mayo Clinic

Publications: 89

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 88

Jihad H. Kaouk

Jihad H. Kaouk

Cleveland Clinic

Publications: 84

Liang Cheng

Liang Cheng

Indiana University

Publications: 82

Vincenzo Ficarra

Vincenzo Ficarra

University of Udine

Publications: 81

Toni K. Choueiri

Toni K. Choueiri

Harvard University

Publications: 75

Michael L. Blute

Michael L. Blute

Harvard University

Publications: 66

Trending Scientists

Alejandro Ribeiro

Alejandro Ribeiro

University of Pennsylvania

F.C.T. van der Helm

F.C.T. van der Helm

Delft University of Technology

Gion Calzaferri

Gion Calzaferri

University of Bern

Tina M. Nenoff

Tina M. Nenoff

Sandia National Laboratories

Shuqiang Jiao

Shuqiang Jiao

University of Science and Technology Beijing

Stacy Steinberg

Stacy Steinberg

deCODE Genetics (Iceland)

Kenneth T. Frank

Kenneth T. Frank

Bedford Institute of Oceanography

Andrew D. Austin

Andrew D. Austin

University of Adelaide

Michel Génard

Michel Génard

INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement

Haruo Onda

Haruo Onda

Takeda (Japan)

Dieter H. Wolf

Dieter H. Wolf

University of Stuttgart

James E. Simon

James E. Simon

Rutgers, The State University of New Jersey

Giovanni Bertotti

Giovanni Bertotti

Delft University of Technology

Joshua Elliott

Joshua Elliott

University of Chicago

Michelle M. Wander

Michelle M. Wander

University of Illinois at Urbana-Champaign

Nizar M. Tannir

Nizar M. Tannir

The University of Texas MD Anderson Cancer Center

Something went wrong. Please try again later.